Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 248

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

α‐enolase: a promising therapeutic and diagnostic tumor target

Open access
Capello, Michela, Ferri‐Borgogno, Sammy, Cappello, Paola, Novelli, Francesco · 2011 · The FEBS Journal

Abstract

α‐enolase (ENOA) is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and thus mediates activation of plasmin and extracellular matrix degradation. In tumor cells, ΕΝΟΑ is upregulated and supports anaerobic proliferation (Warburg effect), it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post‐translational modifications, namely acetylation, methylation and phosphorylation. Both ENOA overexpression and its post‐translational modifications could be of diagnostic and prognostic value in cancer. This review will discuss recent information on the biochemical, proteomics and immunological characterization of ENOA, particularly its ability to trigger a specific humoral and cellular immune response. In our opinion, this information can pave the way for effective new therapeutic and diagnostic strategies to counteract the growth of the most aggressive human disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1742-4658.2011.08025.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 248

Metadata

Authors
Capello, M., Ferri‐Borgogno, S., Cappello, P., & Novelli, F.
Venue
The FEBS Journal
Publisher
Wiley
Published
2011-02-24
Volume
278
Issue
7
Pages
1064-1074
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W1669342046
Cited by
248
References
6
FWCI
6.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: α‐enolase: a promising therapeutic and diagnostic tumor target. https://app.cochat.ai/papers/10.1111/j.1742-4658.2011.08025.x
The paper
Capello, M., Ferri‐Borgogno, S., Cappello, P., & Novelli, F. (2011). α‐enolase: a promising therapeutic and diagnostic tumor target. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2011.08025.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.